Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark F Naylor

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
American Family Physician|August 17, 2002
Facial rashRaymond T Kuwahara, Mark F Naylor, Robert B Skinner
Pediatric Dermatology|February 1, 2003
Treatment of granuloma annulare with topical 5% imiquimod creamRaymond T Kuwahara, Mark F Naylor, Robert B Skinner
Journal of Biophotonics|April 19, 2017
Treatment of advanced melanoma with laser immunotherapy and ipilimumabMark F Naylor, Feifan Zhou, Brian V Geister, et al.
Cancer|April 22, 2009
Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention TrialVincent D Criscione, Martin A Weinstock, Mark F Naylor, et al.
Theranostics|January 27, 2021
Cancer photo-immunotherapy: from bench to bedsideMiao Wang, Jie Rao, Meng Wang, et al.
Cancer Biology & Therapy|October 5, 2010
Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary studyXiaosong Li, Mark F Naylor, Henry Le, et al.
Cancer Letters|January 31, 2015
InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunityFeifan Zhou, Xiaosong Li, Mark F Naylor, et al.
JAMA Dermatology|October 17, 2012
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoidesStuart R Lessin, Madeleine Duvic, Joan Guitart, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
American Family Physician|August 17, 2002
Facial rashRaymond T Kuwahara, Mark F Naylor, Robert B Skinner
Pediatric Dermatology|February 1, 2003
Treatment of granuloma annulare with topical 5% imiquimod creamRaymond T Kuwahara, Mark F Naylor, Robert B Skinner
Journal of Biophotonics|April 19, 2017
Treatment of advanced melanoma with laser immunotherapy and ipilimumabMark F Naylor, Feifan Zhou, Brian V Geister, et al.
Cancer|April 22, 2009
Actinic keratoses: Natural history and risk of malignant transformation in the Veterans Affairs Topical Tretinoin Chemoprevention TrialVincent D Criscione, Martin A Weinstock, Mark F Naylor, et al.
Theranostics|January 27, 2021
Cancer photo-immunotherapy: from bench to bedsideMiao Wang, Jie Rao, Meng Wang, et al.
Cancer Biology & Therapy|October 5, 2010
Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary studyXiaosong Li, Mark F Naylor, Henry Le, et al.
Cancer Letters|January 31, 2015
InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunityFeifan Zhou, Xiaosong Li, Mark F Naylor, et al.
JAMA Dermatology|October 17, 2012
Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoidesStuart R Lessin, Madeleine Duvic, Joan Guitart, et al.
Pageof 1